| Primary |
| Drug Use For Unknown Indication |
39.5% |
| Drug Exposure During Pregnancy |
10.8% |
| Insomnia |
7.2% |
| Suicide Attempt |
7.2% |
| Anticoagulant Therapy |
4.8% |
| Cardiac Failure |
4.8% |
| Product Used For Unknown Indication |
3.0% |
| Adjuvant Therapy |
2.4% |
| Constipation |
2.4% |
| Hyperchlorhydria |
2.4% |
| Hypothyroidism |
2.4% |
| Major Depression |
2.4% |
| Menopausal Symptoms |
2.4% |
| Oedema |
2.4% |
| Thrombosis Prophylaxis |
2.4% |
| Hypertension |
1.2% |
| Hyperuricaemia |
1.2% |
| Migraine |
1.2% |
|
| Drug Toxicity |
16.0% |
| Dizziness |
12.0% |
| Withdrawal Syndrome |
12.0% |
| Hepatic Function Abnormal |
8.0% |
| Somnolence |
8.0% |
| Water Intoxication |
8.0% |
| Drug Dependence |
4.0% |
| Fall |
4.0% |
| Hepatic Steatosis |
4.0% |
| Liver Disorder |
4.0% |
| Multiple Drug Overdose Intentional |
4.0% |
| No Therapeutic Response |
4.0% |
| Platelet Count Decreased |
4.0% |
| Premature Rupture Of Membranes |
4.0% |
| Sopor |
4.0% |
|
| Secondary |
| Insomnia |
16.3% |
| Product Used For Unknown Indication |
14.4% |
| Alcoholic Psychosis |
8.8% |
| Irritability |
8.8% |
| Depression |
8.2% |
| Intentional Overdose |
6.2% |
| Mental Disorder |
5.8% |
| Drug Use For Unknown Indication |
5.5% |
| Cardiac Failure |
5.4% |
| Schizophrenia |
4.4% |
| Constipation |
2.1% |
| Cough |
1.8% |
| Atrial Fibrillation |
1.6% |
| Cardiac Failure Congestive |
1.6% |
| Constipation Prophylaxis |
1.6% |
| Diabetes Mellitus |
1.6% |
| Major Depression |
1.6% |
| Thrombosis Prophylaxis |
1.6% |
| Ventricular Tachycardia |
1.6% |
| Bipolar Ii Disorder |
1.4% |
|
| Neuroleptic Malignant Syndrome |
17.0% |
| Circulatory Collapse |
10.2% |
| Overdose |
6.8% |
| Suicide Attempt |
6.8% |
| Disseminated Intravascular Coagulation |
5.7% |
| Toxic Epidermal Necrolysis |
5.7% |
| Pallanaesthesia |
4.5% |
| Rhabdomyolysis |
4.5% |
| White Blood Cell Count Increased |
4.5% |
| Cardiac Failure Congestive |
3.4% |
| Condition Aggravated |
3.4% |
| Disease Progression |
3.4% |
| Histiocytosis Haematophagic |
3.4% |
| Intentional Overdose |
3.4% |
| Sedation |
3.4% |
| Somnolence |
3.4% |
| Sudden Death |
3.4% |
| Cardiac Death |
2.3% |
| Dehydration |
2.3% |
| Dyspnoea |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
18.7% |
| Insomnia |
17.2% |
| Drug Use For Unknown Indication |
7.6% |
| Rheumatoid Arthritis |
5.7% |
| Depression |
5.6% |
| Hiv Infection |
5.3% |
| Constipation |
5.0% |
| Hypertension |
5.0% |
| Prophylaxis |
4.5% |
| Schizophrenia |
4.1% |
| Hepatitis C |
3.6% |
| Diabetes Mellitus |
3.2% |
| Gastritis |
2.3% |
| Pain |
2.0% |
| Headache |
1.9% |
| Bipolar Disorder |
1.9% |
| Gastric Ulcer |
1.8% |
| Malnutrition |
1.5% |
| Urinary Retention |
1.5% |
| Acute Myeloid Leukaemia |
1.5% |
|
| Pneumonia |
7.6% |
| Tremor |
7.6% |
| Liver Injury |
6.8% |
| Vomiting |
6.1% |
| Weight Decreased |
6.1% |
| Insomnia |
5.3% |
| Rhabdomyolysis |
5.3% |
| Toxic Epidermal Necrolysis |
5.3% |
| Completed Suicide |
4.5% |
| Neutropenia |
4.5% |
| Renal Failure Acute |
4.5% |
| Sepsis |
4.5% |
| Somnolence |
4.5% |
| White Blood Cell Count Decreased |
4.5% |
| Anaphylactic Shock |
3.8% |
| Convulsion |
3.8% |
| Nausea |
3.8% |
| Speech Disorder |
3.8% |
| Sudden Death |
3.8% |
| Weight Increased |
3.8% |
|
| Interacting |
|
| Blood Triglycerides Increased |
100.0% |
|
